We’re excited to be attending the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. The Delcath team is looking forward to connecting with the oncology community, sharing insights, and supporting conversations around innovation in the treatment landscape for patients with liver-dominant metastatic disease. If you’ll be at #ASCO, we’d love to connect. #ASCO26 #Oncology #CancerCare #MedicalInnovation #Healthcare
Delcath Systems
Pharmaceutical Manufacturing
New York, NY 8,410 followers
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of metastatic liver cancer.
About us
Delcath Systems, Inc. (NASDAQ- DCTH) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product---Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. Delcath is in late-stage clinical development in the United States with initial commercial activities in Europe, where the Melphalan/HDS is marketed as a CE Marked device under the trade name Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT). Our commercial strategy for CHEMOSAT is to steadily grow clinical adoption in major European markets and utilize physician experience to support appeals for reimbursement. Since launch over 250 CHEMOSAT treatments have been performed at over 20 leading European cancer centers. In 2016, we launched our FOCUS Pivotal Study in Hepatic Dominant Ocular Melanoma, and are investigating orphan indications in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. We believe Melphalan/HDS is uniquely positioned to treat the entire liver as a stand-alone or complementary therapy.
- Website
-
http://www.delcath.com
External link for Delcath Systems
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Public Company
- Founded
- 1987
- Specialties
- Oncology, Research & Development, Liver Cancers, Ocular Melanoma, Intrahepatic cholangiocarcinoma, Hepatocellular carcinoma, Uveal Melanoma, Metastatic Uveal Melanoma, Hepatic dominant uveal melanoma, and Liver directed therapy
Locations
-
Primary
Get directions
1633 Broadway
22nd Floor, Suite C
New York, NY 10019, US
-
Get directions
Unit 19 Mervue Business Park
Galway, IE
-
Get directions
566 Queensbury Avenue
Queensbury, NY 12804, US
Employees at Delcath Systems
Updates
-
Ocular melanoma begins in the eye, but it can behave differently than other melanomas. When it spreads, it can affect the liver. Increasing awareness of disease progression helps support informed conversations and ongoing research. #OcularMelanoma #CancerAwareness #Oncology
-
-
Proud to join the community at the Boston #MilesForMelanoma 5K hosted by the Melanoma Research Foundation. At Delcath, we remain committed to supporting awareness, advocacy, and education efforts for the melanoma community including those impacted by metastatic uveal melanoma. Thank you to everyone who participated, shared their stories, and helped move this important mission forward. #MelanomaAwareness #UvealMelanoma #Delcath #Boston
-
-
We’re wearing eye patches to better understand what patients with ocular melanoma may experience and to support a cause that matters. Even a short time without full vision can change how you navigate the world, impacting depth perception, awareness, and everyday tasks. Today, on #EyePatchDay, we’re joining the community in raising awareness and standing with patients. Learn more from A Cure In Sight™ and Eye on Grace Foundation. #OcularMelanoma #CancerAwareness
-
“Wearing an eye patch… gave me a lot more appreciation for people who have lost their vision.” Sometimes it only takes a small shift in perspective to better understand what others may be going through. We’re proud to take part in #EyePatchDay and support awareness for ocular melanoma. #OcularMelanoma #CancerAwareness
-
“It’s definitely something you take for granted… when you can use both eyes at all times.” Wearing an eye patch, even briefly, changes how you see the world. This Ocular Melanoma Awareness Month, we’re taking part in the #EyePatchChallenge to help raise awareness and encourage conversations around eye health. #EyePatchDay #OcularMelanoma #CancerAwareness
-
We’re proud to support the Melanoma Research Foundation Miles for Melanoma 5K in Boston on May 16. This event unites the melanoma community to advance awareness and fund critical research. If you’re local, join us and help drive progress forward. Register or donate today. https://lnkd.in/eDGeP9nX
-
-
Looking for a simple way to get involved this Ocular Melanoma Awareness Month? Take the #EyePatchChallenge: • Put on an eye patch • Share your photo • Help raise awareness Community efforts like those led by Eye on Grace Foundation are helping bring people together to support patients and fund research. Learn more and get involved: eyeongracefoundation.org #OcularMelanoma #CancerAwareness
-
-
It’s often detected during a comprehensive dilated eye exam, not because of symptoms. That’s why routine eye exams matter. If it’s been a while, consider scheduling one and encourage someone in your life to do the same. #OcularMelanoma #EyeHealth #EarlyDetection
-
One day. One patch. Big impact. Eye Patch Day is May 15. Help raise awareness for ocular melanoma and encourage conversations around eye health. You can get involved by wearing an eye patch and sharing why awareness matters. Learn more and request a free eye patch from A Cure In Sight™. We’ll be participating. Stay tuned! #EyePatchChallenge #OcularMelanoma #CancerAwareness
👁️ Eye Patch Day is May 15th! Join us in spreading awareness for ocular melanoma by wearing your eye patch proudly and encouraging others to get a comprehensive dilated eye exam. 🎯 Order your FREE eye patch today: https://lnkd.in/dRc4RcTm Get involved: ✨ Organize a fundraiser or event: https://lnkd.in/gin55aTu ✨ Decorate your eye patch or wear it for a day—complete tasks and share your experience ✨ Send your photos/videos to Megan@ACureInSight.org by May 14th Together, we can raise awareness, spark conversations, and make an impact.